Komori
Noevir Holdings (4928) · TargetRestatedLatest Results (2026-11-10): "Advanced"

Improving Capital Efficiency and ROE

First written in FY2017. 5 of 10 entries say "Advanced", first in FY2018. Latest entry: 2026-11-10.

10entries
10years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseWorsenedFY2019 – FY2020AdvancedFY2021 – FY20222017: 12018: 120182019: 120192020: 120202021: 120212022: 120222023: 120232024: 120242025: 120252026: 12026
Same theme, other companies
Improving Capital Efficiency and Profitability Through ROE and ROICA theme 395 companies write about · 7 as a headwind · 398 as a tailwind

Noevir Holdings moved to the "Worse" side of this theme in 2019, 4 years before the typical company in this theme (2023).

The whole theme swung hardest in 2021: 30 of 115 companies on the "Worse" side.

47 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 193 companies compared. The sentences above are computed from all 193.Comparing 200 of the theme's 406 threads.
Full recordFilings, disclosures and news, newest first
  1. 2026-11-10AdvancedResults

    「2026年9月期 15.2 13.0 15.0」

    自己資本当期純利益率(ROE)は前期の15.0%から15.2%へ上昇した。
  2. FY2025RestatedAnnual report

    「Return on equity 14.6 15.0 We intend to continue working to improve return on equity in preparation for future business development.」

    ROE was 15.0% in both the previous and current fiscal years, and the policy of improving ROE remains in place.
  3. FY2024AdvancedAnnual report

    「Return on equity 14.6 15.0 We intend to continue working to improve return on equity in preparation for future business development.」

    ROE rose from 14.6% in the previous fiscal year to 15.0%, and the policy of improving ROE remains in place.
  4. FY2023RestatedAnnual report

    「Return on equity 14.6 We intend to continue working to improve return on equity in preparation for future business development.」

    ROE was unchanged from the previous fiscal year at 14.6%, and the policy of improving ROE remains in place.
  5. FY2022AdvancedAnnual report

    「Return on equity 14.6 We intend to continue working to improve return on equity in preparation for future business development.」

    ROE rose from 12.3% in the previous fiscal year to 14.6%, and the policy of improving ROE remains in place.
  6. FY2021AdvancedAnnual report

    「Return on equity 12.3 We intend to continue working to improve return on equity in preparation for future business development.」

    ROE rose from 10.7% in the previous fiscal year to 12.3%, and the policy of improving ROE remains in place.
  7. FY2020WorsenedAnnual report

    「Return on equity 10.7 We intend to continue working to improve return on equity in preparation for future business development.」

    The policy of improving ROE remains in place, although consolidated ROE declined from 13.8% in the previous fiscal year to 10.7%.
  8. FY2019WorsenedAnnual report

    「Return on equity 13.8 We intend to continue working to improve return on equity in preparation for future business development.」

    The policy of improving ROE remains in place, although consolidated ROE declined from 14.1% in the previous fiscal year to 13.8%.
  9. FY2018AdvancedAnnual report

    「Return on equity 12.3 14.1 We intend to continue working to improve return on equity in preparation for future business development.」

    The policy of improving ROE remains in place, while consolidated ROE rose from 12.3% in the previous fiscal year to 14.1% in the current fiscal year.
  10. FY2017First statedAnnual report

    「We intend to continue working to improve return on equity in preparation for future business development.」

    In its explanations of dividend and capital policies, the company explicitly states its aim of improving ROE alongside making future investments.
Moved together

"Declining Sales and Continuing Losses in Other Businesses" moved the same way as this thread, in the same document, in 4 of its 10 moves.

444433★123456
  1. ★This thread
  2. 1Declining Sales and Continuing Losses in Other Businesses4×
  3. 2Shareholder Returns Through Dividends4×
  4. 3Expanding the Cosmetics Customer Base Through New Products and Existing Series4×
  5. 4Strengthening the R&D Structure and Collaboration with Academic Institutions4×
  6. 5Cosmetics Business Revenue and Profit Growth3×
  7. 6Lower revenue and segment loss in the pharmaceuticals and food business3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Noevir Holdings's next results are scheduled for 2026-11-10. Read the earnings preview It last moved in the Results of 2026-11-10: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.